Jeffrey Conklin

Title: Innovations by Jeffrey Conklin in Medical Technology

Introduction

Jeffrey Conklin is a notable inventor based in Los Angeles, CA, who has made significant contributions to the field of medical technology. With a total of three patents to his name, his work focuses on innovative solutions for treating various medical conditions.

Latest Patents

One of Conklin's latest patents is titled "Systems and methods for electrically stimulating the lower esophageal sphincter to treat gastroesophageal reflux disease." This invention describes methods and devices that utilize electrical stimulation to modulate lower esophageal sphincter (LES) pressure. The electrical stimulation is delivered to the LES via electrodes placed in contact with the LES tissue. This technology is particularly useful for treating gastroesophageal reflux disease (GERD). Another significant patent is "Use of GLP-1 receptor agonists for the treatment of short bowel syndrome." This invention outlines methods for using incretin mimetics, such as GLP-1 receptor agonists, specifically exenatide, to treat short bowel syndrome and spastic or hyperactive esophageal motor disorders.

Career Highlights

Throughout his career, Jeffrey Conklin has worked with prominent organizations, including Endostim, Inc. and Cedars-Sinai Medical Center. His experience in these institutions has allowed him to develop and refine his innovative medical technologies.

Collaborations

Conklin has collaborated with notable professionals in the field, including Edy E. Soffer and Mark Pimentel. These collaborations have contributed to the advancement of his inventions and the impact they have on medical treatments.

Conclusion

Jeffrey Conklin's work exemplifies the spirit of innovation in medical technology. His patents address critical health issues and demonstrate his commitment to improving patient care through advanced solutions.